Clinically, these findings underscore the importance of BMI management, weight reduction and lifestyle modification may mitigate the risk of MetS among individuals with low eGDR, and metabolic assessments should consider both insulin sensitivity and body weight control strategies. The gene discussed is INS; the disease is metabolic syndrome.